Cytokine response patterns in severe pandemic 2009 h1n1 and seasonal influenza among hospitalized adults

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Lee, Nelson ^a   Wong, Chun Kwok ^a   Chan, Paul K S ^a   Chan, Martin C W ^a   Wong, Rity Y K ^a   Lun, Samantha W M ^a   Ngai, Karry L K ^a   Lui, Grace C Y ^a   Wong, Bonnie C K ^a   Lee, Sharon K W ^a   Choi, Kin Wing ^a   Hui, David S C ^a  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

CXCL9 CHEMOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; CHEMOKINE; CYTOKINE;

2009 H1N1 INFLUENZA; ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGED; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; DEOXYGENATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; EX VIVO STUDY; FATTY ACID DESATURATION; FEMALE; FEVER; FLOW CYTOMETRY; HOSPITALIZATION; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SEASONAL INFLUENZA; SEX DIFFERENCE; TACHYPNEA; TH1 CELL; TH17 CELL; VIRAL CLEARANCE; BIOSYNTHESIS; BLOOD; CHINA; IMMUNOLOGY; INFLUENZA; INFLUENZA VIRUS A H1N1; MONONUCLEAR CELL; PANDEMIC; PHYSIOLOGY; SEASON; STATISTICS; VIROLOGY;

ADULT; CHEMOKINES; CHINA; CYTOKINES; FEMALE; HOSPITALIZATION; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA, HUMAN; LEUKOCYTES, MONONUCLEAR; MALE; PANDEMICS; SEASONS;

EID: 80054070717     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026050     Document Type: Article

References (45)

1. World Health Organization. Influenza 1 Available http://www.who.int/topics/influenza/en. Accessed 2011 May.
2. Bautista E, Chotpitayasunondh T, Gao Z, Harper SA, Shaw M, et al. (2010) Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection. N Engl J Med 362: 1708-1719.
3. Centre for Health Protection.Department of Health, The Government of the Hong Kong SAR. 1 Available http://www.chp.gov.hk/en/view_content/14843.html. Accessed 2011 May.
4. Ison MG, Lee N, (2010) Influenza 2010-2011: lessons from the 2009 pandemic. Cleve Clin J Med 77: 812-820.
5. Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, et al. (2009) Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med 361: 1935-1944.
6. Louie JK, Acosta M, Winter K, Jean C, Gavali S, et al. (2009) Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 302: 1896-1902.
7. Lee N, Chan PK, Lui GC, Wong BC, Sin WW, et al. (2011) Complications and Outcomes of Pandemic 2009 Influenza A (H1N1) Virus Infection in Hospitalized Adults - how are they Different from Seasonal Influenza? J Infect Dis 203: 1739-1747.
8. Lee N, Chan PK, Wong CK, Wong KT, Choi KW, et al. (2011) Viral clearance and inflammatory response patterns in adults hospitalized for pandemic 2009 influenza A(H1N1) virus pneumonia. Antivir Ther 16: 237-247.
9. To KK, Hung IF, Li IW, Lee KL, Koo CK, et al. (2010) Delayed clearance of viral load and marked cytokine activation in severe cases of pandemic H1N1 2009 influenza virus infection. Clin Infect Dis 50: 850-859.
10. van den Brand JM, Stittelaar KJ, van Amerongen G, Rimmelzwaan GF, Simon J, et al. (2010) Severity of pneumonia due to new H1N1 influenza virus in ferrets is intermediate between that due to seasonal H1N1 virus and highly pathogenic avian influenza H5N1 virus. J Infect Dis 201: 993-999.
11. Geiler J, Michaelis M, Sithisarn P, Cinatl J Jr, (2011) Comparison of pro-inflammatory cytokine expression and cellular signal transduction in human macrophages infected with different influenza A viruses. Med Microbiol Immunol 200: 53-60.
12. Chan MC, Chan RW, Yu WC, Ho CC, Yuen KM, et al. (2010) Tropism and innate host responses of the 2009 pandemic H1N1 influenza virus in ex vivo and in vitro cultures of human conjunctiva and respiratory tract. Am J Pathol 176: 1828-1840.
13. Peiris JS, Cheung CY, Leung CY, Nicholls JM, (2009) Innate immune responses to influenza A H5N1: friend or foe? Trends Immunol 30: 574-584.
14. Lee N, Chan PK, Hui DS, Rainer TH, Wong E, et al. (2009) Viral loads and duration of viral shedding in adult patients hospitalized with influenza.J Infect Dis 200: 492-500.
15. Lee N, Wong CK, Chan PK, Lun SW, Lui G, et al. (2007) Hypercytokinemia and hyperactivation of phospho-p38 mitogen-activated protein kinase in severe human influenza A virus infection. Clin Infect Dis 45: 723-731.
16. Lit LCW, Wong CK, Li EK, Tam LS, Lam CWK, (2006) Elevated plasma concentration and ex vivo production of inflammatory chemokines in patients with systemic lupus erythematosus. Annals Rhe Dis 65: 209-215.
17. Rigato O, Salomao R, (2003) Impaired production of interferon-gamma and tumor necrosis factor-alpha but not of interleukin 10 in whole blood of patients with sepsis. Shock 19: 113-116.
18. Hussain R, Kaleem A, Shahid F, Dojki M, Jamil B, et al. (2002) Cytokine profiles using whole-blood assays can discriminate between tuberculosis patients and healthy endemic controls in a BCG-vaccinated population. J Immunol Methods 264: 95-108.
19. Hagau N, Slavcovici A, Gonganau DN, Oltean S, Dirzu DS, et al. (2010) Clinical aspects and cytokine response in severe H1N1 influenza A virus infection. Crit Care 14:R203. Epub 2010 Nov 9.
20. Bermejo-Martin JF, Ortiz de Lejarazu R, Pumarola T, Rello J, Almansa R, et al. (2009) Th1 and Th17 hypercytokinemia as early host response signature in severe pandemic influenza. Crit Care 13: R201.
21. Bermejo-Martin JF, Martin-Loeches I, Rello J, Antón A, Almansa R, et al. (2010) Host adaptive immunity deficiency in severe pandemic influenza. Crit Care 14: R167.
22. Sato M, Hosoya M, Wright PF, (2009) Differences in serum cytokine levels between influenza virus A and B infections in children. Cytokine 47: 65-68.
23. Svitek N, Rudd PA, Obojes K, Pillet S, von Messling V, (2008) Severe seasonal influenza in ferrets correlates with reduced interferon and increased IL-6 induction. Virology 376: 53-59.
24. Wu W, Booth JL, Duggan ES, Wu S, Patel KB, et al. (2010) Innate immune response to H3N2 and H1N1 influenza virus infection in a human lung organ culture model. Virology 396: 178-188.
25. McGill J, Heusel JW, Legge KL, (2009) Innate immune control and regulation of influenza virus infections. J Leukoc Biol 86: 803-812.
26. Arankalle VA, Lole KS, Arya RP, Tripathy AS, Ramdasi AY, et al. (2010) Role of host immune response and viral load in the differential outcome of pandemic H1N1 (2009) influenza virus infection in Indian patients. PLoS One 5(10). pii.
27. Longhi MP, Wright K, Lauder SN, Nowell MA, Jones GW, et al. (2008) Interleukin-6 is crucial for recall of influenza-specific memory CD4 T cells. PLoS Pathog 4 (2): e1000006.
28. Lee SM, Chan RW, Gardy JL, Lo CK, Sihoe AD, et al. (2010) Systems-level comparison of host responses induced by pandemic and seasonal influenza A H1N1 viruses in primary human type I-like alveolar epithelial cells in vitro. Respir Res 11: 147.
29. de Jong MD, Simmons CP, Thanh TT, Hien VM, Smith GJ, et al. (2006) Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia. Nat Med 12: 1203-1207.
30. Osterlund P, Pirhonen J, Ikonen N, Rönkkö E, Strengell M, et al. (2010) Pandemic H1N1 2009 influenza A virus induces weak cytokine responses in human macrophages and dendritic cells and is highly sensitive to the antiviral actions of interferons. J Virol 84: 1414-1422.
31. Agrati C, Gioia C, Lalle E, Cimini E, Castilletti C, et al. (2010) Association of profoundly impaired immune competence in H1N1v-infected patients with a severe or fatal clinical course. J Infect Dis 202: 681-689.
32. Jiang TJ, Zhang JY, Li WG, Xie YX, Zhang XW, et al. (2010) Preferential loss of Th17 cells is associated with CD4 T cell activation in patients with 2009 pandemic H1N1 swine-origin influenza A infection. Clin Immunol 137: 303-310.
33. Miossec P, Korn T, Kuchroo VK, (2009) Interleukin-17 and type 17 helper T cells. N Engl J Med 361: 888-898.
34. Crowe CR, Chen K, Pociask DA, Alcorn JF, Krivich C, et al. (2009) Critical role of IL-17RA in immunopathology of influenza infection. J Immunol 183: 5301-5310.
35. Kudva A, Scheller EV, Robinson KM, Crowe CR, Choi SM, et al. (2011) Influenza A inhibits Th17-mediated host defense against bacterial pneumonia in mice. J Immunol 186: 1666-1674.
36. Hamada H, Garcia-Hernandez Mde L, Reome JB, Misra SK, Strutt TM, et al. (2009) Tc17, a unique subset of CD8 T cells that can protect against lethal influenza challenge. J Immunol 182: 3469-3481.
37. Giamarellos-Bourboulis EJ, Raftogiannis M, Antonopoulou A, Baziaka F, Koutoukas P, et al. (2009) Effect of the novel influenza A (H1N1) virus in the human immune system. PLoS One 4 (12): e8393.
38. Rowe T, León AJ, Crevar CJ, Carter DM, Xu L, et al. (2010) Modeling host responses in ferrets during A/California/07/2009 influenza infection. Virology 401: 257-265.
39. Baskin CR, Bielefeldt-Ohmann H, Tumpey TM, Sabourin PJ, Long JP, et al. (2009) Early and sustained innate immune response defines pathology and death in nonhuman primates infected by highly pathogenic influenza virus. Proc Natl Acad Sci U S A 106: 3455-3460.
40. Han K, Ma H, An X, Su Y, Chen J, et al. (2011) Early use of glucocorticoids was a risk factor for critical disease and death from pH1N1 infection. Clin Infect Dis 53: 326-333.
41. Brun-Buisson C, Richard JC, Mercat A, Thiébaut AC, Brochard L; for the REVA-SRLF A/H1N1v 2009 Registry Group. (2011) Early Corticosteroids in Severe Influenza A/H1N1 Pneumonia and Acute Respiratory Distress Syndrome. Am J Respir Crit Care Med 183: 1200-1206.
42. Lee N, Hui DS, (2011) Corticosteroids in community-acquired pneumonia. Lancet. In press.
43. Simmons C, Farrar J, (2008) Insights into inflammation and influenza. N Engl J Med 359: 1621-1623.
44. Hui DS, Lee N, Chan PK, (2010) Clinical management of pandemic 2009 influenza A(H1N1) infection. Chest 137: 916-925.
45. Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, et al. (2011) Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proc Natl Acad Sci U S A 108: 12018-12023.